ARTICLE
2 July 2020

MSRB Updates FAQs On COVID-19 Regulatory Relief

HL
Hogan Lovells Cadwalader

Contributor

Hogan Lovells Cadwalader is a global law firm trusted by clients to deliver on complex, high-stakes matters.

Operating at the intersection of business, finance, and government, we bring an unwavering commitment to client service and the decisive counsel that helps clients achieve exceptional results.

Consistently recognized for innovation across legal services, we combine sharp judgment with deep commercial perspective and intellectual rigor to address critical, cutting-edge challenges.

With 3,100 lawyers worldwide, we offer global scale with strong local insight in the markets that matter most. Our commitment extends beyond client work through pro bono activities, community investment, and responsible business practices.

The MSRB updated its FAQs for regulated entities concerning COVID-19-related regulatory relief.
United States Coronavirus (COVID-19)
Hogan Lovells Cadwalader are most popular:
  • within Intellectual Property, International Law, Food, Drugs, Healthcare and Life Sciences topic(s)

The MSRB updated its FAQs for regulated entities concerning COVID-19-related regulatory relief. The additional guidance addresses the application of a recent SEC Order granting temporary conditional relief to registered municipal advisors soliciting certain qualified providers for direct placements by municipal issuers in light of MSRB Rule G-23 (see prior coverage here and here).

The FAQs address, among other things:

  • relief from examination requirements under MSRB Rule G-3 ("Professional Qualification Requirements");
  • supervisory considerations under MSRB Rule G-27 ("Supervision");
  • transaction reporting obligations under Federal Reserve Board facilities;
  • the process for providing customers with markup disclosures pursuant to MSRB Rule G-15 ("Confirmation, Clearance, Settlement and Other Uniform Practice Requirements with Respect to Transactions with Customers"); and
  • best execution obligations under MSRB Rule G-18 ("Best Execution") and fair pricing obligations under MSRB Rule G-30 ("Prices and Commissions").

Primary Sources

  1. MSRB FAQ: Frequently Asked Questions Related to COVID-19 Pandemic Regulatory Relief

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More